The internet can be an easy way to access therapeutic goods. But be careful about buying medicines or medical devices online.
We regulate medicines and medical devices supplied in Australia. When you buy medicines online, we don't know who made them, or what's in them. And neither do you.
You can't tell if they are counterfeit (fake), toxic or have illegal ingredients. Counterfeit medicines and medical devices are often packaged to look like the real product.
Seek advice from your doctor or health professional if you're unsure about a health product.
- PageBuying medicines and medical devices onlineSee our information and video on the risks of buying health products online.
- PageCounterfeit (fake) medicines and medical devicesIf you use counterfeit medicines or medical devices you are risking your health.
Latest alerts
- Safety alertsEVE Allylisopropylacetylurea tabletsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
- Safety alertsCounterfeit semaglutide vialsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
- Safety alertsNew safety warning for medicines used in arthritis and other inflammatory conditionsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
Latest articles
- Media releases2023 Seasonal Influenza VaccinesInfluenza vaccines can change from year to year as new strains of influenza virus appear. This is one reason vaccination against influenza is given every year.
- Safety updatesOral anticoagulants can cause serious kidney damage in rare circumstancesA warning about anticoagulant-related nephropathy (ARN) has been added to the Product Information (PI) for all oral anticoagulants.
- NewsLifeblood sexual activity and PrEP deferralsThe TGA has approved applications submitted by Australian Red Cross Lifeblood (Lifeblood) to remove most of the sexual activity ineligibility criteria for plasma donors used for fractionated products only. Lifeblood refers to this approach as ‘the plasma pathway’.